Report Detail

Pharma & Healthcare Global (United States, European Union and China) Hematopoietic Stem Cells (HSCs) Market Research Report 2019-2025

  • RnM3499349
  • |
  • 06 June, 2019
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

In 2019, the market size of Hematopoietic Stem Cells (HSCs) is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hematopoietic Stem Cells (HSCs).

This report studies the global market size of Hematopoietic Stem Cells (HSCs), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Hematopoietic Stem Cells (HSCs) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Kite Pharma Inc.
Thermo Fisher Scientific
PromoCell
CellGenix Technologie Transfer GmbH
Cesca Therapeutics Inc.
R&D Systems
Genlantis
Lonza Group Ltd.
TiGenix N.V.
ScienCell Research Laboratories
China Cord Blood Corporation
Vcanbio
Boyalife
Beike Biotechnology

Market Segment by Product Type
Leukocyte
Lymphocytes
Red Blood Cells
Platelets

Market Segment by Application
Blood System Diseases
Autoimmune Diseases
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Hematopoietic Stem Cells (HSCs) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Hematopoietic Stem Cells (HSCs) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Hematopoietic Stem Cells (HSCs) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Hematopoietic Stem Cells (HSCs) Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Leukocyte
      • 1.3.3 Lymphocytes
      • 1.3.4 Red Blood Cells
      • 1.3.5 Platelets
    • 1.4 Market Segment by Application
      • 1.4.1 Global Hematopoietic Stem Cells (HSCs) Market Share by Application (2019-2025)
      • 1.4.2 Blood System Diseases
      • 1.4.3 Autoimmune Diseases
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Hematopoietic Stem Cells (HSCs) Market Size
      • 2.1.1 Global Hematopoietic Stem Cells (HSCs) Revenue 2014-2025
      • 2.1.2 Global Hematopoietic Stem Cells (HSCs) Sales 2014-2025
    • 2.2 Hematopoietic Stem Cells (HSCs) Growth Rate by Regions
      • 2.2.1 Global Hematopoietic Stem Cells (HSCs) Sales by Regions 2014-2019
      • 2.2.2 Global Hematopoietic Stem Cells (HSCs) Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Hematopoietic Stem Cells (HSCs) Sales by Manufacturers
      • 3.1.1 Hematopoietic Stem Cells (HSCs) Sales by Manufacturers 2014-2019
      • 3.1.2 Hematopoietic Stem Cells (HSCs) Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Hematopoietic Stem Cells (HSCs) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Hematopoietic Stem Cells (HSCs) Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Hematopoietic Stem Cells (HSCs) Market Concentration Ratio (CR5 and HHI)
    • 3.3 Hematopoietic Stem Cells (HSCs) Price by Manufacturers
    • 3.4 Key Manufacturers Hematopoietic Stem Cells (HSCs) Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Hematopoietic Stem Cells (HSCs) Market
    • 3.6 Key Manufacturers Hematopoietic Stem Cells (HSCs) Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Leukocyte Sales and Revenue (2014-2019)
      • 4.1.2 Lymphocytes Sales and Revenue (2014-2019)
      • 4.1.3 Red Blood Cells Sales and Revenue (2014-2019)
      • 4.1.4 Platelets Sales and Revenue (2014-2019)
    • 4.2 Global Hematopoietic Stem Cells (HSCs) Sales Market Share by Type
    • 4.3 Global Hematopoietic Stem Cells (HSCs) Revenue Market Share by Type
    • 4.4 Hematopoietic Stem Cells (HSCs) Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Hematopoietic Stem Cells (HSCs) Sales by Application

    6 United States

    • 6.1 United States Hematopoietic Stem Cells (HSCs) Breakdown Data by Company
    • 6.2 United States Hematopoietic Stem Cells (HSCs) Breakdown Data by Type
    • 6.3 United States Hematopoietic Stem Cells (HSCs) Breakdown Data by Application

    7 European Union

    • 7.1 European Union Hematopoietic Stem Cells (HSCs) Breakdown Data by Company
    • 7.2 European Union Hematopoietic Stem Cells (HSCs) Breakdown Data by Type
    • 7.3 European Union Hematopoietic Stem Cells (HSCs) Breakdown Data by Application

    8 China

    • 8.1 China Hematopoietic Stem Cells (HSCs) Breakdown Data by Company
    • 8.2 China Hematopoietic Stem Cells (HSCs) Breakdown Data by Type
    • 8.3 China Hematopoietic Stem Cells (HSCs) Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Hematopoietic Stem Cells (HSCs) Breakdown Data by Company
    • 9.2 Rest of World Hematopoietic Stem Cells (HSCs) Breakdown Data by Type
    • 9.3 Rest of World Hematopoietic Stem Cells (HSCs) Breakdown Data by Application
    • 9.4 Rest of World Hematopoietic Stem Cells (HSCs) Breakdown Data by Countries
      • 9.4.1 Rest of World Hematopoietic Stem Cells (HSCs) Sales by Countries
      • 9.4.2 Rest of World Hematopoietic Stem Cells (HSCs) Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Kite Pharma Inc.
      • 10.1.1 Kite Pharma Inc. Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Hematopoietic Stem Cells (HSCs)
      • 10.1.4 Hematopoietic Stem Cells (HSCs) Product Introduction
      • 10.1.5 Kite Pharma Inc. Recent Development
    • 10.2 Thermo Fisher Scientific
      • 10.2.1 Thermo Fisher Scientific Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Hematopoietic Stem Cells (HSCs)
      • 10.2.4 Hematopoietic Stem Cells (HSCs) Product Introduction
      • 10.2.5 Thermo Fisher Scientific Recent Development
    • 10.3 PromoCell
      • 10.3.1 PromoCell Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Hematopoietic Stem Cells (HSCs)
      • 10.3.4 Hematopoietic Stem Cells (HSCs) Product Introduction
      • 10.3.5 PromoCell Recent Development
    • 10.4 CellGenix Technologie Transfer GmbH
      • 10.4.1 CellGenix Technologie Transfer GmbH Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Hematopoietic Stem Cells (HSCs)
      • 10.4.4 Hematopoietic Stem Cells (HSCs) Product Introduction
      • 10.4.5 CellGenix Technologie Transfer GmbH Recent Development
    • 10.5 Cesca Therapeutics Inc.
      • 10.5.1 Cesca Therapeutics Inc. Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Hematopoietic Stem Cells (HSCs)
      • 10.5.4 Hematopoietic Stem Cells (HSCs) Product Introduction
      • 10.5.5 Cesca Therapeutics Inc. Recent Development
    • 10.6 R&D Systems
      • 10.6.1 R&D Systems Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Hematopoietic Stem Cells (HSCs)
      • 10.6.4 Hematopoietic Stem Cells (HSCs) Product Introduction
      • 10.6.5 R&D Systems Recent Development
    • 10.7 Genlantis
      • 10.7.1 Genlantis Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Hematopoietic Stem Cells (HSCs)
      • 10.7.4 Hematopoietic Stem Cells (HSCs) Product Introduction
      • 10.7.5 Genlantis Recent Development
    • 10.8 Lonza Group Ltd.
      • 10.8.1 Lonza Group Ltd. Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Hematopoietic Stem Cells (HSCs)
      • 10.8.4 Hematopoietic Stem Cells (HSCs) Product Introduction
      • 10.8.5 Lonza Group Ltd. Recent Development
    • 10.9 TiGenix N.V.
      • 10.9.1 TiGenix N.V. Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Hematopoietic Stem Cells (HSCs)
      • 10.9.4 Hematopoietic Stem Cells (HSCs) Product Introduction
      • 10.9.5 TiGenix N.V. Recent Development
    • 10.10 ScienCell Research Laboratories
      • 10.10.1 ScienCell Research Laboratories Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Hematopoietic Stem Cells (HSCs)
      • 10.10.4 Hematopoietic Stem Cells (HSCs) Product Introduction
      • 10.10.5 ScienCell Research Laboratories Recent Development
    • 10.11 China Cord Blood Corporation
    • 10.12 Vcanbio
    • 10.13 Boyalife
    • 10.14 Beike Biotechnology

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Hematopoietic Stem Cells (HSCs) Sales Channels
      • 11.2.2 Hematopoietic Stem Cells (HSCs) Distributors
    • 11.3 Hematopoietic Stem Cells (HSCs) Customers

    12 Market Forecast

    • 12.1 Global Hematopoietic Stem Cells (HSCs) Sales and Revenue Forecast 2019-2025
    • 12.2 Global Hematopoietic Stem Cells (HSCs) Sales Forecast by Type
    • 12.3 Global Hematopoietic Stem Cells (HSCs) Sales Forecast by Application
    • 12.4 Hematopoietic Stem Cells (HSCs) Forecast by Regions
      • 12.4.1 Global Hematopoietic Stem Cells (HSCs) Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Hematopoietic Stem Cells (HSCs) Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Hematopoietic Stem Cells (HSCs) . Industry analysis & Market Report on Hematopoietic Stem Cells (HSCs) is a syndicated market report, published as Global (United States, European Union and China) Hematopoietic Stem Cells (HSCs) Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Hematopoietic Stem Cells (HSCs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,624.00
      3,936.00
      5,248.00
      3,063.52
      4,595.28
      6,127.04
      518,043.20
      777,064.80
      1,036,086.40
      273,650.40
      410,475.60
      547,300.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report